Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report) rose 6.2% during trading on Friday . The stock traded as high as $4.6021 and last traded at $4.60. Approximately 1,300 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 4,390 shares. The stock had previously closed at $4.33.
Knight Therapeutics Price Performance
The firm has a 50-day moving average price of $4.31 and a two-hundred day moving average price of $4.38.
About Knight Therapeutics
Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.
Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.
Featured Articles
- Five stocks we like better than Knight Therapeutics
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
